Skip to main content
Log in

In vitro activity of four fluoroquinolones against eighty-six isolates of mycobacteria

  • Notes
  • Published:
European Journal of Clinical Microbiology Aims and scope Submit manuscript

Abstract

The in vitro activity of pefloxacin, norfloxacin, ofloxacin and ciprofloxacin against 86 strains of mycobacteria was evaluated by broth dilution. While Mycobacterium avium, Mycobacterium scrofulaceum and Mycobacterium chelonae were resistant to all four antibacterials, the susceptibility of the other species,Mycobacterium tuberculosis, Mycobacterium kansasii, Mycobacterium xenopi and Mycobacterium fortuitum,depended on the antibiotic. Ofloxacin and ciprofloxacin (MIC90: 0.5 – 2 mg/l) were more active than pefloxacin and norfloxacin (MIC90: 2–16 mg/l).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Grosset, J., Boisvert, H., Lagrange, P., Baranton, G.: Mycobactéries. In: Le Minor, L., Véron, M. (ed.): Bactériologie Médicale. Flammarion médecine sciences, Paris, 1982, p. 657–703.

    Google Scholar 

  2. Grosset, J., Jarlier, V., Truffot-Pernot, C., Guelpa-Lauras, C. C., Lecoeur, H.: Activité des nouvelles quinolones sur les mycobactéries. In: Pocidalo, F., Vachon, B., Regnier, B. (ed.): Les nouvelles quinolones. Arnette, Paris, 1985, p. 181–189.

    Google Scholar 

  3. Fenlon, C. H., Cynamon, M. H.: Comparative in-vitro activities of ciprofloxacin and other 4-quinolones againstMycobacterium tuberculosis andMycobacterium intracellulare. Antimicrobial Agents and Chemotherapy 1986, 29: 386–388.

    PubMed  Google Scholar 

  4. Collins, C. H., Uttley, A. H.: In-vitro susceptibility of mycobacteria to ciprofloxacin. Journal of Antimicrobial Chemotherapy 1985, 16: 575–580.

    PubMed  Google Scholar 

  5. Tsukamura, M.: In-vitro antimycobacterial activity of a new antibacterial substance DL 8280. Differentiation between some species of mycobacteria and related organisms by the DL 8280 susceptibility test. Microbiology and Immunology 1983, 27: 1129–1132.

    PubMed  Google Scholar 

  6. Gay, J. D., De Young, D. R., Roberts, G. D.: In-vitro activities of norfloxacin and ciprofloxacin againstMycobacterium tuberculosis, M. avium complex,M. chelonei, M. fortuitum andM. kansasii. Antimicrobial Agents and Chemotherapy 1984, 26: 94–96.

    PubMed  Google Scholar 

  7. Tsukamura, M., Nakamura, E., Yoshii, S., Amano, H.: Therapeutic effect of a new antibacterial substance ofloxacin (DL 8280) on pulmonary tuberculosis. American Review of Respiratory Diseases 1985, 131: 352–356.

    Google Scholar 

  8. Fur, A., Massin, F., Camus, P. H., Waldner, A., Jeannin, L.: Traitement de sauvetage d'une tuberculose pulmonaire multi-résistante: efficacité de la pefloxacine. Presse Médicale, 1987, 16: 128.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Texier-Maugein, J., Mormède, M., Fourche, J. et al. In vitro activity of four fluoroquinolones against eighty-six isolates of mycobacteria. Eur. J, Clin. Microbiol. 6, 584–586 (1987). https://doi.org/10.1007/BF02014255

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02014255

Keywords

Navigation